MedTrace Logo

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

NCT05029583 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2024-01-24

No results posted yet for this study

Summary

The study is stratified cluster randomized trial. The study population will include adults with T2D and presumed NASH.

Conditions

Interventions

OTHER

routine screening

routine screening for advanced NASH

OTHER

physician-driven screening

physician-driven screening for advanced NASH

Sponsors & Collaborators

  • LMC Diabetes & Endocrinology Ltd.

    lead OTHER

Principal Investigators

  • Harpreet Bajaj, MD · LMC Diabetes & Endocrinology Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-11
Primary Completion
2025-10-05
Completion
2025-10-05

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05029583 on ClinicalTrials.gov